Skip to content
Trial Eligibility
Menu

Improving Coronary Vascular Health in Women

NCT06843902

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Women with HIV have an increased risk of having a myocardial infarction (heart attack) as compared to women without HIV. One of the mechanisms underlying the increased risk of myocardial infarction among women with HIV may involve reduced ability to increase blood flow through large and small coronary arteries at times when increased flow of oxygen-carrying blood is needed.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • HIV-1-infection
  • Coronary Microvascular Dysfunction
  • Metabolic Disease

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
45 to 75 years
Sex
Female
Healthy volunteers
Not accepted
Sponsor
Massachusetts General Hospital
Last updated on ClinicalTrials.gov
September 8, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 1

  • Massachusetts General Hospital · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.